Please assess the completion status of the following clinical trial:

Trial Title: Drugs in Lactation Analysis Consortium

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: OTHER
- Primary Purpose: None
- Time Perspective: CROSS_SECTIONAL
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Age over 18 years old Taking one or more drugs of interest of the study, at steady state~Exclusion Criteria:~* Being unable to communicate in English, Colostrum phase (\<1 week postpartum)

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Breastfeeding women on the study medications (Type: None): The study population consists of lactating/breastfeeding women over the age of 18, who are able to communicate in English and are taking one or more of the study drugs (Infliximab, Adalimumab, Golimumab, Certolizumab, Etanercept, Methotrexate, Ezetimibe, Bupropion, Citalopram, Venlafaxine)

Based on this trial design, predict the completion outcome and termination type (if applicable).